Global Syndromic Testing Market Analysis and Forecast 2019-2028
$2,800.00 – $5,440.00
Technological advancements in molecular diagnostics fuel the demand for syndromic testing globally
The global syndromic testing market is expected to witness a significant growth rate of more than 7% during the forecast period. The global syndromic testing market is a rapidly growing segment of the healthcare industry, driven by the increasing demand for accurate and rapid diagnostic tests. These tests are used for the diagnosis of various infectious diseases, including respiratory infections, sexually transmitted infections, and gastrointestinal infections.
The market is driven by several key drivers such as the increasing prevalence of infectious diseases, rising demand for rapid diagnostics tests, and technological advancements in molecular diagnostics. Moreover, increasing government incentives and funding for research coupled with growing awareness about the benefits of early diagnosis are also expected to drive the demand for the syndromic testing market across the globe.
The respiratory panel is expected to dominate the market owing to the high prevalence of respiratory infections
The respiratory panel segment is expected to dominate the global syndromic testing market, accounting for the largest market share. This is due to the high prevalence of respiratory infections, such as flu, pneumonia, and bronchitis, which are responsible for a significant proportion of hospital admissions and healthcare costs globally. In addition, respiratory panel tests are widely available and are used by healthcare providers for the diagnosis of multiple respiratory pathogens simultaneously.
However, the gastrointestinal panel segment is expected to grow at a strong CAGR during the forecast period. This is attributed to the increasing incidence of gastrointestinal infections, such as norovirus, rotavirus, and Clostridium difficile, which cause severe diarrhea and vomiting. Furthermore, gastrointestinal panel tests are used for the rapid and accurate diagnosis of these infections, and their demand is expected to increase in the coming years due to their efficiency and reliability.
Advanced diagnostic technologies coupled with the well-established healthcare sector helped North America to dominate the global syndromic testing market
North America is anticipated to dominate the syndromic testing market and accounted for the major market share due to the presence of well-established healthcare infrastructure, advanced diagnostic technologies, and high healthcare expenditure. Europe is also one of the prominent regions for syndromic testing with significant growth potential due to the increasing adoption of molecular diagnostic technologies and the rising incidence of infectious diseases.
The Asia-Pacific region is expected to witness the uppermost growth rate in the coming years, driven by factors such as increasing healthcare expenditure, rising awareness about early diagnosis, and the growing prevalence of infectious diseases. Latin America and the Middle East & Africa are also expected to witness significant growth in the syndromic testing market in the coming years. The growing demand for rapid diagnostic tests, increasing investments in healthcare infrastructure, and rising awareness about infectious diseases are some of the key drivers of market growth in these regions.
Market Structure and Competitive Landscape
The global syndromic testing market is fragmented in nature with the presence of various players in the market. Some of the prominent players operating in the global syndromic testing market include BioFire Diagnostics, Luminex Corporation, Alere Inc, Becton, Dickinson and Company, Cepheid Inc., GenMark Diagnostics Inc., Hologic Inc., Quidel Corporation, Siemens Healthineers, and Thermo Fisher Scientific Inc. among others. These players adopt various strategies including mergers and acquisitions, partnerships and collaborations which directly results in propelling the growth of the global syndromic testing market.
Key Market Segmentation
RationalStat has segmented the global syndromic testing market on the basis of product / services, panels type, disease, end use, and region.
- By Product / Services
- Reagents & Consumables
- Instruments, Software & Accessories
- Services
- By Panels Type
- Respiratory Panel
- GI-Enteric Panel
- Sexually Transmitted Disease Panel
- Blood-Sepsis Panel
- Others (Meningitis Panel, etc.)
- By Disease
- Respiratory Infection
- Gastroenteritis
- Sexually Transmitted Infections
- Sepsis
- Others (Meningitis, etc.)
- By End User
- Hospitals
- Diagnostic labs
- Others (ASCs etc.)
- By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Western Europe
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- South Africa
- Turkey
- Rest of the Middle East & Africa
- North America
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecast, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Secondary Sources
- Annual reports, company filings, investor presentations, product catalogs, and company documents
- Industry and market-related documents available in the public domain
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, Thomson Reuters, among others
- Whitepapers, research papers, and industry blogs.
Why Buy this Report?
The report is intended for Syndromic testing providers, healthcare industry, government organizations, educational organizations, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption patterns, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global syndromic testing market is expected to grow at a CAGR of over 7.2% during the forecast period 2022-2028.
North America is dominating the global syndromic testing market in 2022.
Rising demand for rapid diagnostics tests is the key driver of the global syndromic testing market.
Major companies operating in the global syndromic testing market include BioFire Diagnostics, Luminex Corporation, Alere Inc, Becton, Dickinson and Company, Cepheid Inc., GenMark Diagnostics Inc., Hologic Inc., Quidel Corporation, Siemens Healthineers, and Thermo Fisher Scientific Inc, etc.
| REGION | Global |
|---|---|
| RELEASE YEAR | 2023 |
| RESEARCH CODE | RST-SAR-128 |
| ADDITIONAL FEATURE | 24×7 Post sales support and 15% free customization |
| User License | Single User/Team License, Corporate License |
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
5.1. Impact on Growth Strategies
5.2. Impact on Operations and Supply Chain
5.3. Impact on R&D Spendings
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players’ expenditures, and economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.3.1.Raw Material Suppliers
6.3.2.Equipment Manufacturers & Suppliers
6.3.3.Physicians
6.3.4.Hospitals and Medical Center
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global Syndromic Testing Market: Technology Assessment
Robust assessment of key technologies incorporated in various types of Syndromic Testing services that are commercialized in the marketplace
10. Syndromic Testing Equipment Production
11. Investment Analysis
11.1. M&A Activities
11.2. Key Investment by Major Players in the Market
Robust assessment of major investments made by various industry players along with key application areas, technological assessment, and key applications
12. Market Spending and Use Case Analysis
12.1. By Leading Players
12.2. By Leading Hospitals / Institutions
12.3. By Region
13. Parent Market Overview: Global Healthcare Market Overview
14. Segmental Analysis
14.1. Global Syndromic Testing Market by Product / Service in terms of Value (US$ Million) and Volume (000’ units)
14.1.1. Reagents & Consumables
14.1.2. Instruments, Software & Accessories
14.1.3. Services
14.2. Global Syndromic Testing Market by Panels Type in terms of Value (US$ Million)
14.2.1. Respiratory Panel
14.2.2. GI-Enteric Panel
14.2.3. Sexually Transmitted Disease Panel
14.2.4. Blood-Sepsis Panel
14.2.5. Others (Meningitis Panel, etc.)
14.3. Global Syndromic Testing Market by Disease in terms of Value (US$ Million)
14.3.1. Respiratory Infection
14.3.2. Gastroenteritis
14.3.3. Sexually Transmitted Infections
14.3.4. Sepsis
14.3.5. Others (Meningitis, etc.)
14.4. Global Syndromic Testing Market by End User in terms of Value (US$ Million)
14.4.1. Hospitals
14.4.2. Diagnostic labs
14.4.3. Others (ASCs etc.)
14.5. Global Syndromic Testing Market by Region in terms of Value (US$ Million)
14.5.1. North America
14.5.2. Latin America
14.5.3. Western Europe
14.5.4. Eastern Europe
14.5.5. Asia Pacific
14.5.6. Middle East & Africa
15. Regional Analysis
15.1. North America Syndromic Testing Market Analysis and Forecast 2019-2028
15.1.1. Regional Market Overview and Key Takeaways
15.1.2. North America Syndromic Testing Market by Product / Service
15.1.3. North America Syndromic Testing Market by Panels Type
15.1.4. North America Syndromic Testing Market by Disease
15.1.5. North America Syndromic Testing Market by End User
15.1.6. North America Syndromic Testing Market by Country
15.1.6.1. US
15.2. Asia Pacific Syndromic Testing Market Analysis and Forecast 2019-2028
15.2.1. Regional Market Overview and Key Takeaways
15.2.2. Asia Pacific Syndromic Testing Market by Product / Service
15.2.3. Asia Pacific Syndromic Testing Market by Panels Type
15.2.4. Asia Pacific Syndromic Testing Market by Disease
15.2.5. Asia Pacific Syndromic Testing Market by End User
15.2.6. Asia Pacific Syndromic Testing Market by Country
15.2.6.1. China
15.2.6.2. Japan
15.2.6.3. India
15.2.6.4. South Korea
15.2.6.5. Australia
15.2.6.6. ASEAN
15.2.6.7. Rest of Asia-Pacific
15.3. Western Europe Syndromic Testing Market Analysis and Forecast 2019-2028
15.3.1. Regional Market Overview and Key Takeaways
15.3.2. Western Europe Syndromic Testing Market by Product / Service
15.3.3. Western Europe Syndromic Testing Market by Panels Type
15.3.4. Western Europe Syndromic Testing Market by Disease
15.3.5. Western Europe Syndromic Testing Market by End User
15.3.6. Western Europe Syndromic Testing Market by Country
15.3.6.1. Germany
15.3.6.2. UK
15.3.6.3. France
15.3.6.4. Spain
15.3.6.5. Italy
15.3.6.6. Benelux
15.3.6.7. Nordic
15.3.6.8. Rest of Western Europe
15.4. Eastern Europe Syndromic Testing Market Analysis and Forecast 2019-2028
15.4.1. Regional Market Overview and Key Takeaways
15.4.2. Eastern Europe Syndromic Testing Market by Product / Service
15.4.3. Eastern Europe Syndromic Testing Market by Panels Type
15.4.4. Eastern Europe Syndromic Testing Market by Disease
15.4.5. Eastern Europe Syndromic Testing Market by End User
15.4.6. Eastern Europe Syndromic Testing Market by Country
15.4.6.1. Russia
15.4.6.2. Poland
15.4.6.3. Rest of Eastern Europe
15.5. Latin America Syndromic Testing Market Analysis and Forecast 2019-2028
15.5.1. Regional Market Overview and Key Takeaways
15.5.2. Latin America Syndromic Testing Market by Product / Service
15.5.3. Latin America Syndromic Testing Market by Panels Type
15.5.4. Latin America Syndromic Testing Market by Disease
15.5.5. Latin America Syndromic Testing Market by End User
15.5.6. Latin America Syndromic Testing Market by Country
15.5.6.1. Brazil
15.5.6.2. Mexico
15.5.6.3. Rest of Latin America
15.6. Middle East & Africa Syndromic Testing Market Analysis and Forecast 2019-2028
15.6.1. Regional Market Overview and Key Takeaways
15.6.2. Middle East & Africa Syndromic Testing Market by Product / Service
15.6.3. Middle East & Africa Syndromic Testing Market by Panels Type
15.6.4. Middle East & Africa Syndromic Testing Market by Disease
15.6.5. Middle East & Africa Syndromic Testing Market by End User
15.6.6. Middle East & Africa Syndromic Testing Market by Country
15.6.6.1. GCC
15.6.6.2. South Africa
15.6.6.3. Turkey
15.6.6.4. Rest of the Middle East & Africa
16. Competitive Landscape
16.1. Competition Dashboard
16.1.1. Global and Regional Market Share Analysis
16.1.2. Market Structure
16.2. Competitive Benchmarking
16.3. Key Strategy Analysis
16.4. Company Profiles
16.4.1. BioFire Diagnostics
16.4.1.1. Company Overview
16.4.1.2. Product/Service Offerings
16.4.1.3. Financials
16.4.1.4. Recent Developments
16.4.2. Luminex Corporation
16.4.2.1. Company Overview
16.4.2.2. Product/Service Offerings
16.4.2.3. Key Financials
16.4.2.4. Recent Developments
16.4.3. Alere Inc
16.4.3.1. Company Overview
16.4.3.2. Product/Service Offerings
16.4.3.3. Key Financials
16.4.3.4. Recent Developments
16.4.4. Becton, Dickinson and Company
16.4.4.1. Company Overview
16.4.4.2. Product/Service Offerings
16.4.4.3. Financials
16.4.4.4. Recent Developments
16.4.5. Cepheid Inc.
16.4.5.1. Company Overview
16.4.5.2. Product/Service Offerings
16.4.5.3. Financials
16.4.5.4. Recent Developments
16.4.6. GenMark Diagnostics Inc.
16.4.6.1. Company Overview
16.4.6.2. Product/Service Offerings
16.4.6.3. Financials
16.4.6.4. Recent Developments
16.4.7. Hologic Inc.
16.4.7.1. Company Overview
16.4.7.2. Product/Service Offerings
16.4.7.3. Financials
16.4.7.4. Recent Developments
16.4.8. Quidel Corporation
16.4.8.1. Company Overview
16.4.8.2. Product/Service Offerings
16.4.8.3. Financials
16.4.8.4. Recent Developments
16.4.9. Siemens Healthineers
16.4.9.1. Company Overview
16.4.9.2. Product/Service Offerings
16.4.9.3. Financials
16.4.9.4. Recent Developments
16.4.10. Thermo Fisher Scientific Inc.
16.4.10.1. Company Overview
16.4.10.2. Product/Service Offerings
16.4.10.3. Financials
16.4.10.4. Recent Developments
*This list is not exhaustive, RationalStat will provide a detailed list of more than 50+ Syndromic Testing companies that are operating in Global and regional market.
17. Disclaimer
Every Sample Includes
Research Methodology
Complete Table of Contents, List of Charts and Tables
Exclusive Facts & Illustrations
Related products
Healthcare & Pharmaceutical
Global Advanced Wound Care Market Analysis and Forecast, 2023-2030
Market Introduction: Key Takeaways The global advanced wound care market was valued at US$ 9.87 billion in 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2028. The market is being driven by an increasing incidence of chronic diseases such as diabetes, obesity, and cancer, which often lead to chronic [...]
Healthcare & Pharmaceutical
Growth Opportunity Analysis in the Global Biologics Outsourcing Market
Increasing demand for the highly efficient biotherapeutics from the value-centric patient population globally is propelling the market growth
Healthcare & Pharmaceutical
Global Osteoporosis Treatment Market Analysis and Forecast 2019-2028
Market Introduction: Key Takeaways The global osteoporosis treatment market is expected to grow at a CAGR of 4.8% during the forecast period of 2023-2028, according to a RationalStat market report. Osteoporosis is a condition characterized by low bone density and increased risk of fractures, and it is a significant global health concern, particularly among the [...]
Healthcare & Pharmaceutical
Global Cartilage Repair and Cartilage Regeneration Market Analysis and Forecast, 2022-2028
The global Cartilage Repair and Cartilage Regeneration Market is expected to grow at a CAGR of 8% over the forecast period of 2022-2028.
Healthcare & Pharmaceutical
Global mRNA Technology Market: Investment & Growth Opportunity Analysis, 2020-2030
Increasing investments and R&D activities in mRNA-based technologies are fueling the market growth
Healthcare & Pharmaceutical
Global Veterinary Eye Care Therapeutics Market Analysis and Forecast, 2023-2030
The global veterinary eye care therapeutics market is estimated at US$ 780-800 million in 2022 and is expected to grow at a significant CAGR of 3.7% over the forecast period of 2022-2030.